On August 31, 2026, EDGE MEDICAL-B (02675) allocated HK$892,900 to repurchase 25,600 of its own shares.
The buyback transaction was disclosed in a recent company filing, highlighting the firm's ongoing capital management efforts.
This move reflects EDGE MEDICAL-B's strategy to consolidate shareholder value through targeted market purchases.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.